TCRT Reports Positive Preclinical ALN1003 Data, Shows 12.9% Body Weight Reduction, Improved Insulin Sensitivity, and Enhanced Liver Health in Obese Mouse Studies
Alaunos Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $2.87
+18% in 3d after detection
Post-detection moves
1h
-3.7%
1d
+16%
3d
+18%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS